samedan logo

 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Ardena expands capacity to satisfy Novavax COVID vaccine demand

Ardena



Gent, Belgium/December 2021: Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO), announced it will be expanding its capacity for purification and fractionation of GMP manufacturing at its site in Södertälje, Sweden. The expansion will satisfy long-term demand expected from Novavax for production of the company’s COVID-19 vaccine, among others.

The expansion comes following the grant of conditional marketing authorisation by the European Commission for Novavax’s COVID-19 vaccine, Nuvaxovid.

For 15 years, Ardena has been proud to partner with Novavax on the development of the fractionation process for their proprietary Matrix-M™ adjuvant, a key component of the vaccine. Only the fifth vaccine approved in Europe, Nuvaxovid is a recombinant protein-based vaccine co-formulated with Matrix-M adjuvant to enhance an immune response.

The expansion plan includes additional chromatography, tangential flow filtration and lyophilisation capabilities. Speaking of the plans Harry Christiaens, Ardena CEO, said: “This announcement will significantly enhance our ability to help Novavax deliver more vaccines. It makes me proud that our company is part of the continuing innovation and multiple partnerships going on worldwide to tackle COVID-19.”
phone +32 9 267 65 00
web https://ardena.com/
email Kleimoer 4, 9030 Gent
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Cumulus Neuroscience Commences Clinical Studies of Digital Biomarker Platform in Degenerative Neurological Diseases

Belfast, UK – 25 May 2022. Cumulus Neuroscience, a global digital health company, announces the start of two validation trials – CNS-101 and CNS-102 – supported by a group of leading global pharma companies and Innovate UK. The studies will investigate the potential benefits of Cumulus’ integrated physiological and digital biomarker platform in quantifying cognitive decline over time in patients with dementia, across AD, ALS and FTD.
More info >>


White Papers

Maximize the ROI of Your Post-Approval Research

Bioclinica

Expenditures in post-approval (Phase IV) research are going up across the pharmaceutical, biotech and medical device industries. Given the resources you’ve committed to post-approval research, you may be wondering if you’re getting the greatest possible return on your investment. Discover how to harness the power of post-approval research to increase data collection, reduce resource burn, save money, and maximize your ROI!
More info >>

Industry Events

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022)

20-21 June 2022, Berlin, Germany

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) is held on June, 20-21, 2022 in Berlin, Germany. The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies to discuss the manufacturing and packaging processes of the pharmaceutical industry. Among the participating companies are Bayer, Sandoz, Merck, Novartis, Roche, Genveon, Samsung Biologics, Pfizer.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement